These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 7835022

  • 21. Sulfasalazine induced lupus in rheumatoid arthritis.
    Caulier M, Dromer C, Andrieu V, Le Guennec P, Fournie B.
    J Rheumatol; 1994 Apr; 21(4):750-1. PubMed ID: 7913504
    [Abstract] [Full Text] [Related]

  • 22. Sulphasalazine-induced lupus in psoriatic arthritis.
    Veale DJ, Ho M, Morley KD.
    Br J Rheumatol; 1995 Apr; 34(4):383-4. PubMed ID: 7788157
    [Abstract] [Full Text] [Related]

  • 23. D-penicillamine and lupus erythematosuslike syndrome.
    Harkcom TM, Conn DL, Holley KE.
    Ann Intern Med; 1978 Dec; 89(6):1012. PubMed ID: 717982
    [No Abstract] [Full Text] [Related]

  • 24. Sulphasalazine in rheumatoid arthritis.
    Crisp AJ.
    Br J Rheumatol; 1984 Aug; 23(3):232. PubMed ID: 6146376
    [No Abstract] [Full Text] [Related]

  • 25. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA.
    Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract] [Full Text] [Related]

  • 26. [A case report of rheumatoid arthritis which showed acute renal failure, nephrotic syndrome and drug-related lupus-like syndrome caused by D-penicillamine].
    Suda M, Yoshikawa Y, Suzuki T, Dohi Y, Shibata T.
    Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1235-41. PubMed ID: 2082056
    [Abstract] [Full Text] [Related]

  • 27. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A, Rothfield NF.
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [Abstract] [Full Text] [Related]

  • 28. Penicillamine-induced SLE.
    Walshe JM.
    Lancet; 1986 Apr; 2(8260-61):1416. PubMed ID: 6118779
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
    Camus JP, Crouzet J, Prier A, Leca AP.
    Therapie; 1976 Apr; 31(3):385-97. PubMed ID: 136767
    [No Abstract] [Full Text] [Related]

  • 31. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA, Marabani M, Madhok R, Torley H, Hunter JA.
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.